Yifan Pharmaceutical Co., Ltd. (SHE:002019)

Yifan Pharmaceutical Revenue

Yifan Pharmaceutical had revenue of 1.26B CNY in the quarter ending March 31, 2026, a decrease of -5.36%. This brings the company's revenue in the last twelve months to 5.06B, down -1.91% year-over-year. In the year 2025, Yifan Pharmaceutical had annual revenue of 5.13B, down -0.52%.

• Revenue (ttm): 5.06B
• Revenue Growth: -1.91%
• P/S Ratio: 2.29
• Revenue / Employee: 1.21M
• Employees: 4,182
• Market Cap: 11.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.13B	-26.87M	-0.52%
Dec 31, 2024	5.16B	1.09B	26.84%
Dec 31, 2023	4.07B	231.47M	6.03%
Jan 1, 2023	3.84B	-572.39M	-12.98%
Jan 1, 2022	4.41B	-991.34M	-18.36%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error